{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:46:24Z","timestamp":1792586784699,"version":"4.5.0"},"reference-count":40,"publisher":"MyJove Corporation","issue":"233","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70033","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:04:40Z","timestamp":1783119880000},"source":"Crossref","is-referenced-by-count":0,"title":["Automated Machine Learning Model for Non-Alcoholic Fatty Liver Disease Prediction and External Cohort Validation"],"prefix":"10.3791","author":[{"given":"Mingjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishengdan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","type":"journal-article","article-title":"Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovascular diabetology. 2024;23(1):188.","journal-title":"Cardiovascular diabetology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1337241","DOI":"10.3389\/fimmu.2024.1337241","type":"journal-article","article-title":"Systemic immune-inflammatory biomarkers (SII, NLR, PLR, and LMR) linked to non-alcoholic fatty liver disease risk","volume":"15","author":"Liu","year":"2024","unstructured":"Liu K, Tang S, Liu C, et al. Systemic immune-inflammatory biomarkers (SII, NLR, PLR, and LMR) linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15:1337241.","journal-title":"Front Immunol"},{"issue":"6","key":"ref3","first-page":"890","type":"journal-article","article-title":"Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection","volume":"11","author":"Alizargar","year":"2024","unstructured":"Alizargar A, Chang YL, Alkhaleefah M, Tan TH. Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection. Bioengineering (Basel, Switzerland). 2024;11(6):890-905.","journal-title":"Bioengineering (Basel, Switzerland)"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"2209335","DOI":"10.1080\/07853890.2023.2209335","type":"journal-article","article-title":"Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018","volume":"55","author":"Ji","year":"2023","unstructured":"Ji Y, Wei CB, Gu W, Hou LL. Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018. Annals of medicine. 2023;55(1):2209335.","journal-title":"Annals of medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"20552076241272535","DOI":"10.1177\/20552076241272535","type":"journal-article","article-title":"Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020","volume":"10","author":"Liu","year":"2024","unstructured":"Liu L, Lin J, Liu L, et al. Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020. Digital health. 2024;10:20552076241272535.","journal-title":"Digital health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.04.013","type":"journal-article","article-title":"Data science, artificial intelligence, and machine learning: Opportunities for laboratory medicine and the value of positive regulation","volume":"69","author":"Gruson","year":"2019","unstructured":"Gruson D, Helleputte T, Rousseau P, Gruson D. Data science, artificial intelligence, and machine learning: Opportunities for laboratory medicine and the value of positive regulation. Clinical biochemistry. 2019;69:1-7.","journal-title":"Clinical biochemistry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1275897","DOI":"10.3389\/fmolb.2023.1275897","type":"journal-article","article-title":"Uncovering the immune microenvironment and molecular subtypes of hepatitis B-related liver cirrhosis and developing a stable diagnostic differential model by machine learning and artificial neural networks","volume":"10","author":"Zhang","year":"2023","unstructured":"Zhang S, Jiang C, Jiang L, et al. Uncovering the immune microenvironment and molecular subtypes of hepatitis B-related liver cirrhosis and developing a stable diagnostic differential model by machine learning and artificial neural networks. Frontiers in molecular biosciences. 2023;10:1275897.","journal-title":"Frontiers in molecular biosciences"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"846118","DOI":"10.3389\/fpubh.2022.846118","type":"journal-article","article-title":"A Machine Learning Based Framework to Identify and Classify Non-alcoholic Fatty Liver Disease in a Large-Scale Population","volume":"10","author":"Ji","year":"2022","unstructured":"Ji W, Xue M, Zhang Y, Yao H, Wang Y. A Machine Learning Based Framework to Identify and Classify Non-alcoholic Fatty Liver Disease in a Large-Scale Population. Frontiers in public health. 2022;10:846118.","journal-title":"Frontiers in public health"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10620-015-3952-x","type":"journal-article","article-title":"Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record","volume":"61","author":"Corey","year":"2016","unstructured":"Corey KE, Kartoun U, Zheng H, Shaw SY. Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record. Digestive diseases and sciences. 2016;61(3):913-919.","journal-title":"Digestive diseases and sciences"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmpb.2018.12.032","type":"journal-article","article-title":"Prediction of fatty liver disease using machine learning algorithms","volume":"170","author":"Wu","year":"2019","unstructured":"Wu CC, Yeh WC, Hsu WD, et al. Prediction of fatty liver disease using machine learning algorithms. Computer methods and programs in biomedicine. 2019;170:23-29.","journal-title":"Computer methods and programs in biomedicine"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1038\/s41598-023-30750-5","type":"journal-article","article-title":"Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults","volume":"13","author":"Qin","year":"2023","unstructured":"Qin S, Hou X, Wen Y, et al. Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults. Sci Rep. 2023;13(1):3638.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4304376","DOI":"10.1155\/2018\/4304376","type":"journal-article","article-title":"Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China","volume":"2018","author":"Ma","year":"2018","unstructured":"Ma H, Xu CF, Shen Z, Yu CH, Li YM. Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China. BioMed Research International. 2018;2018:4304376.","journal-title":"BioMed Research International"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.14172","type":"journal-article","article-title":"Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population","volume":"46","author":"Yip","year":"2017","unstructured":"Yip TC, Ma AJ, Wong VW, et al. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. Alimentary pharmacology & therapeutics. 2017;46(4):447-456.","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/gastro\/goaa035","type":"journal-article","article-title":"A novel model for predicting fatty liver disease by means of an artificial neural network","volume":"9","author":"Chen","year":"2021","unstructured":"Chen YS, Chen D, Shen C, et al. A novel model for predicting fatty liver disease by means of an artificial neural network. Gastroenterology report. 2021;9(1):31-37.","journal-title":"Gastroenterology report"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.hbpd.2023.03.009","type":"journal-article","article-title":"Development and validation of machine learning models for nonalcoholic fatty liver disease","volume":"22","author":"Peng","year":"2023","unstructured":"Peng HY, Duan SJ, Pan L, et al. Development and validation of machine learning models for nonalcoholic fatty liver disease. Hepatobiliary & pancreatic diseases international : HBPD INT. 2023;22(6):615-621.","journal-title":"Hepatobiliary & pancreatic diseases international : HBPD INT"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep4.1935","type":"journal-article","article-title":"Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning","volume":"6","author":"Noureddin","year":"2022","unstructured":"Noureddin M, Ntanios F, Malhotra D, et al. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning. Hepatology communications. 2022;6(7):1537-1548.","journal-title":"Hepatology communications"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4254\/wjh.v13.i10.1417","type":"journal-article","article-title":"Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database","volume":"13","author":"Atsawarungruangkit","year":"2021","unstructured":"Atsawarungruangkit A, Laoveeravat P, Promrat K. Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database. World journal of hepatology. 2021;13(10):1417-1427.","journal-title":"World journal of hepatology"},{"issue":"12","key":"ref18","first-page":"1123","type":"journal-article","article-title":"An Artificial Neural Network Model Combined with Dietary Retinol Intake from Different Sources to Predict the Risk of Nonalcoholic Fatty Liver Disease","volume":"36","author":"Liu","year":"2023","unstructured":"Liu C, Zhou SH, Su H, Yang WQ, Lu J. An Artificial Neural Network Model Combined with Dietary Retinol Intake from Different Sources to Predict the Risk of Nonalcoholic Fatty Liver Disease. Biomedical and environmental sciences : BES. 2023;36(12):1123-1135.","journal-title":"Biomedical and environmental sciences : BES"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/DDDT.S495555","type":"journal-article","article-title":"Risk Prediction of Liver Injury in Pediatric Tuberculosis Treatment: Development of an Automated Machine Learning Model","volume":"19","author":"Zeng","year":"2025","unstructured":"Zeng Y, Lu H, Li S, et al. Risk Prediction of Liver Injury in Pediatric Tuberculosis Treatment: Development of an Automated Machine Learning Model. Drug design, development and therapy. 2025;19:239-250.","journal-title":"Drug design, development and therapy"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10278-022-00724-6","type":"journal-article","article-title":"Automated Multimodal Machine Learning for Esophageal Variceal Bleeding Prediction Based on Endoscopy and Structured Data","volume":"36","author":"Wang","year":"2023","unstructured":"Wang Y, Hong Y, Wang Y, et al. Automated Multimodal Machine Learning for Esophageal Variceal Bleeding Prediction Based on Endoscopy and Structured Data. Journal of digital imaging. 2023;36(1):326-338.","journal-title":"Journal of digital imaging"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1038\/s41598-024-62311-9","type":"journal-article","article-title":"Automated machine learning for predicting liver metastasis in patients with gastrointestinal stromal tumor: a SEER-based analysis","volume":"14","author":"Liu","year":"2024","unstructured":"Liu L, Zhang R, Shi Y, Sun J, Xu X. Automated machine learning for predicting liver metastasis in patients with gastrointestinal stromal tumor: a SEER-based analysis. Scientific reports. 2024;14(1):12415.","journal-title":"Scientific reports"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12916-023-02964-x","type":"journal-article","article-title":"Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study","volume":"21","author":"Zhang","year":"2023","unstructured":"Zhang H, Ji J, Liu Z, et al. Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study. BMC medicine. 2023;21(1):270.","journal-title":"BMC medicine"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3350\/cmh.2020.0261","type":"journal-article","article-title":"Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis","volume":"27","author":"Xu","year":"2021","unstructured":"Xu G, Wang YM, Ying MM, et al. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Clin Mol Hepatol. 2021;27(2):329-345.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/HEP.0000000000000908","type":"journal-article","article-title":"Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD","volume":"80","author":"Charu","year":"2024","unstructured":"Charu V, Liang JW, Mannalithara A, Kwong A, Tian L, Kim WR. Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD. Hepatology (Baltimore, Md). 2024;80(5):1184-1195.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.kint.2020.07.035","type":"journal-article","article-title":"A practical guide to multiple imputation of missing data in nephrology","volume":"99","author":"Blazek","year":"2021","unstructured":"Blazek K, van Zwieten A, Saglimbene V, Teixeira-Pinto A. A practical guide to multiple imputation of missing data in nephrology. Kidney international. 2021;99(1):68-74.","journal-title":"Kidney international"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1287916","DOI":"10.3389\/fendo.2023.1287916","type":"journal-article","article-title":"Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes","volume":"14","author":"Wang","year":"2023","unstructured":"Wang S, Lin X, Zhu C, et al. Association between nonalcoholic fatty liver disease and increased glucose-to-albumin ratio in adults without diabetes. Frontiers in endocrinology. 2023;14:1287916.","journal-title":"Frontiers in endocrinology"},{"issue":"Suppl","key":"ref27","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.3350\/cmh.2022.0426","type":"journal-article","article-title":"Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future","volume":"29","author":"Yip","year":"2023","unstructured":"Yip TC, Lyu F, Lin H, et al. Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future. Clin Mol Hepatol. 2023;29(Suppl):S171-s183.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","DOI":"10.3390\/nu15081892","type":"journal-article","article-title":"Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018","volume":"15","author":"Liu","year":"2023","unstructured":"Liu CF, Chien LW. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018. Nutrients. 2023;15(8).","journal-title":"Nutrients"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1620\/tjem.223.227","type":"journal-article","article-title":"Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease","volume":"223","author":"Kim","year":"2011","unstructured":"Kim HL, Chung GE, Park IY, et al. Elevated peripheral blood monocyte fraction in nonalcoholic fatty liver disease. The Tohoku journal of experimental medicine. 2011;223(3):227-233.","journal-title":"The Tohoku journal of experimental medicine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"760981","DOI":"10.3389\/fendo.2021.760981","type":"journal-article","article-title":"Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease","volume":"12","author":"Zhong","year":"2021","unstructured":"Zhong F, Guan L, Lin H, et al. Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease. Frontiers in endocrinology. 2021;12:760981.","journal-title":"Frontiers in endocrinology"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12967-023-04047-0","type":"journal-article","article-title":"Lipid metabolism, BMI, and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis","volume":"21","author":"Lu","year":"2023","unstructured":"Lu S, Xie Q, Kuang M, et al. Lipid metabolism, BMI, and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. Journal of translational medicine. 2023;21(1):192.","journal-title":"Journal of translational medicine"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12876-021-01790-w","type":"journal-article","article-title":"Normalization of \u03b3-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease","volume":"21","author":"Ma","year":"2021","unstructured":"Ma Q, Liao X, Shao C, et al. Normalization of \u03b3-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease. BMC gastroenterology. 2021;21(1):215.","journal-title":"BMC gastroenterology"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1021\/acs.jproteome.4c00204","type":"journal-article","article-title":"Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"23","author":"Li","year":"2024","unstructured":"Li X, Xiao Y, Chen X, et al. Machine Learning Reveals Serum Glycopatterns as Potential Biomarkers for the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD). Journal of proteome research. 2024;23(6):2253-2264.","journal-title":"Journal of proteome research"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.32655","type":"journal-article","article-title":"Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis","volume":"77","author":"Chang","year":"2023","unstructured":"Chang D, Truong E, Mena EA, et al. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis. Hepatology (Baltimore, Md). 2023;77(2):546-557.","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/DMSO.S438652","type":"journal-article","article-title":"Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population","volume":"17","author":"Yang","year":"2024","unstructured":"Yang C, Du T, Zhao Y, et al. Development and Validation of a Risk Prediction Model for NAFLD: A Study Based on a Physical Examination Population. Diabetes, metabolic syndrome and obesity : targets and therapy. 2024;17:143-155.","journal-title":"Diabetes, metabolic syndrome and obesity : targets and therapy"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","type":"journal-article","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.Lipids Health Dis. 2021;20(1):134.","journal-title":"Lipids Health Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"20552076241272535","DOI":"10.1177\/20552076241272535","type":"journal-article","article-title":"Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020","volume":"10","author":"Liu","year":"2024","unstructured":"Liu L, Lin J, Liu L, et al. Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020. Digit Health. 2024;10:20552076241272535.","journal-title":"Digit Health"},{"key":"ref38","first-page":"145","type":"journal-article","article-title":"Leveraging integrative technologies to model complex tissue microenvironments: the emerging role of artificial intelligence and machine learning","volume":"48","author":"Wen","year":"2024","unstructured":"Wen, J., Jiang, L., & Schultheiss, T. (2024). Leveraging integrative technologies to model complex tissue microenvironments: the emerging role of artificial intelligence and machine learning. European Cells & Materials, 48, 145\u2013162.","journal-title":"European Cells & Materials"},{"issue":"2","key":"ref39","first-page":"e20230056","type":"journal-article","article-title":"Integration of artificial intelligence in clinical laboratory practices: opportunities and challenges","volume":"3","author":"Lu","year":"2024","unstructured":"Lu P, Zhang Y, Ren J. Integration of artificial intelligence in clinical laboratory practices: opportunities and challenges. Interdisciplinary Medicine. 2024;3(2):e20230056.","journal-title":"Interdisciplinary Medicine"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12933-024-02439-0","type":"journal-article","article-title":"Construction of machine learning diagnostic models for cardiovascular pan-disease based on blood routine and biochemical detection data","volume":"23","author":"Wang","year":"2024","unstructured":"Wang Z, Gu Y, Huang L, et al. Construction of machine learning diagnostic models for cardiovascular pan-disease based on blood routine and biochemical detection data. Cardiovascular diabetology. 2024;23(1):351.","journal-title":"Cardiovascular diabetology"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/70033\/automated-machine-learning-model-for-non-alcoholic-fatty-liver","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:23:30Z","timestamp":1792585410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70033\/automated-machine-learning-model-for-non-alcoholic-fatty-liver"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":40,"journal-issue":{"issue":"233","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70033","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}